Pneumococcal Infection (DBCOND0031818)

Identifiers

Synonyms
Pneumococcal Infections / Active Pneumococcal Infection / Pneumococcal infection / Pneumococcal infection NOS / Pneumococcal infectious disease (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Cloxacillin
An antibiotic agent used for the treatment of beta-hemolytic streptococcal and pneumococcal infections as well as staphylococcal infections.
Streptococcus pneumoniae type 1 capsular polysaccharide antigen
Streptococcus pneumoniae type 1 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 1 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 10a capsular polysaccharide antigen
Streptococcus pneumoniae type 10a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 10a of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 11a capsular polysaccharide antigen
Streptococcus pneumoniae type 11a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 11a of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 12f capsular polysaccharide antigen
Streptococcus pneumoniae type 12f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 12f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 14 capsular polysaccharide antigen
Streptococcus pneumoniae type 14 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 14 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 15b capsular polysaccharide antigen
Streptococcus pneumoniae type 15b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 15b of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 17f capsular polysaccharide antigen
Streptococcus pneumoniae type 17f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 17f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 18c capsular polysaccharide antigen
Streptococcus pneumoniae type 18c capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 18c of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 19a capsular polysaccharide antigen
Streptococcus pneumoniae type 19a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 19a of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 19f capsular polysaccharide antigen
Streptococcus pneumoniae type 19f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 19f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 2 capsular polysaccharide antigen
Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 2 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 20 capsular polysaccharide antigen
Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 20 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 22f capsular polysaccharide antigen
Streptococcus pneumoniae type 22f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 22f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 23f capsular polysaccharide antigen
Streptococcus pneumoniae type 23f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 23f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 3 capsular polysaccharide antigen
Streptococcus pneumoniae type 3 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 3 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 33f capsular polysaccharide antigen
Streptococcus pneumoniae type 33f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 33f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 4 capsular polysaccharide antigen
Streptococcus pneumoniae type 4 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 4 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 5 capsular polysaccharide antigen
Streptococcus pneumoniae type 5 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 5 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 6b capsular polysaccharide antigen
Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 7f capsular polysaccharide antigen
Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 7f of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 8 capsular polysaccharide antigen
Streptococcus pneumoniae type 8 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 8 of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 9n capsular polysaccharide antigen
Streptococcus pneumoniae type 9n capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9n of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Streptococcus pneumoniae type 9v capsular polysaccharide antigen
Streptococcus pneumoniae type 9v capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9v of Streptococcus pneumoniae. It is an active immunization...
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05425732
Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)prevention3completed
NCT05158140
Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)prevention3completed
NCT06177912
A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)prevention3active_not_recruiting
NCT03467984
A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy InfantsNo drug interventionsprevention2completed
NCT00496093
Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)prevention3completed
NCT00133549
9-valent CRM 197 PneumococcalNo drug interventionsprevention2completed
NCT01863719
Aerosolized and Intravenous Colistin in Healthy Adultstreatment1terminated
NCT02572635
A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVaxNo drug interventionsother1completed
NCT01692886
A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In ChinaNo drug interventionsprevention3completed
NCT01531322
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese SubjectsNo drug interventionsbasic_science1completed
NCT03095326
Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesiaprevention4completed
NCT02260882
Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)prevention4completed
NCT05696080
Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)prevention3completed
NCT02515240
Immune Response to Pneumococcal Vaccination in HIV Infected IndividualsNo drug interventionsprevention0completed
NCT00844467
A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at EHSA Region in the Eastern ProvinceNo drug interventionsNot AvailableNot Availableunknown_status
NCT02558751
Pneumonia Vaccine in Aging HIV Positive Individualsprevention0completed
NCT02463578
Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated VasculitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03619252
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel AgentsNo drug interventionsprevention4completed
NCT01307449
Systems Biology of PNEUMOVAX®23 and PREVNAR 13®basic_scienceNot Availablecompleted
NCT03489018
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infantsprevention4active_not_recruiting
NCT01654263
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccineprevention2completed
NCT02463539
Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated VasculitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00535730
ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)prevention3completed
NCT02279589
Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteersprevention2completed
NCT02062281
Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and AdultsNo drug interventionsprevention4completed
NCT03341195
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in PakistanNo drug interventionspreventionNot Availableunknown_status
NCT00560950
Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)prevention3completed
NCT04665050
Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adults (V116-002)prevention1completed
NCT03549208
A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy AdultsNo drug interventionsprevention1unknown_status
NCT00153543
Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native EldersNo drug interventionsprevention1completed
NCT05380193
Serotype Distribution in Hospitalized Adult with Pneumococcal Community Acquired Pneumonia in FranceNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05412030
A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infantsprevention2recruiting
NCT06608199
A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 VaccineNo drug interventionsprevention3not_yet_recruiting
NCT05920499
The Effect of AUDIT and Feedback on Pneumococcal Vaccination CoverageNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00205803
Study Evaluating Pneumococcal Vaccine in Healthy InfantsNo drug interventionsprevention1 / 2completed
NCT00714064
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothersprevention3completed
NCT00294021
Long-term Impact of Pneumococcal Conjugate Vaccine on CarriageNo drug interventionsNot AvailableNot Availablecompleted
NCT03480802
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)prevention3completed
NCT02225587
Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)prevention3completed
NCT03276754
Immunization To Prevent Acute COPD ExacerbationsNo drug interventionsNot AvailableNot Availableterminated
NCT01513551
The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)prevention2completed
NCT02266277
System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician AlertsNo drug interventionshealth_services_researchNot Availablecompleted
NCT02582047
Influenza Vaccine and Pneumococcal VaccineNo drug interventionsprevention4completed
NCT02116998
Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniaeprevention2completed
NCT00137605
Early Versus Delayed Pneumococcal Vaccination in HIVprevention1 / 2completed
NCT04912297
Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10No drug interventionsNot AvailableNot Availablecompleted
NCT00164411
Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria VaccineNo drug interventionsprevention1completed
NCT01577771
Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina FasoNo drug interventionsprevention4completed
NCT03512288
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy InfantsNo drug interventionsprevention2completed
NCT04384107
Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)prevention3completed
NCT03571607
A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.No drug interventionsprevention3completed
NCT05731115
Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide VaccineNo drug interventionsprevention4completed
NCT03313037
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Ageprevention2completed
NCT01215175
Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)prevention1completed
NCT05767606
Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 YearsNo drug interventionsprevention4not_yet_recruiting
NCT00310349
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear DiseaseNo drug interventionsprevention3unknown_status
NCT00378417
Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypesprevention3completed
NCT01443117
Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenNo drug interventionsprevention2withdrawn
NCT01311024
Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal CarriageNot AvailableNot Availablecompleted
NCT03921424
Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)prevention3completed
NCT03983616
Surveillance of Invasive Pneumococcal Infections in Adults (Excluding Meningitis)No drug interventionsNot AvailableNot Availableunknown_status
NCT04875858
Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic PatientsNo drug interventionsprevention4unknown_status
NCT00744263
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in AdultsNo drug interventionsprevention4completed
NCT00368186
Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.prevention4terminated
NCT05092386
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate VaccineNo drug interventionsprevention1recruiting
NCT04183322
PCV13 in Non-pregnant Papua New Guinean WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT03950622
Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)prevention3completed
NCT02201030
Immunogenicity and Safety Study of NBP606 in Healthy InfantsNo drug interventionsprevention3completed
NCT00492557
Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in AdultsNo drug interventionsprevention3completed
NCT00488826
Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infantsprevention1completed
NCT01446926
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infantsprevention1completed
NCT00500266
Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly SubjectsNo drug interventionsprevention3completed
NCT01899365
An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency DepartmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01193582
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal BacteriaNo drug interventionsprevention4completed
NCT03731182
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)prevention3completed
NCT00873431
Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47No drug interventionsNot Available1completed
NCT02225327
MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccineprevention4completed
NCT02255227
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBDprevention2terminated
NCT02955160
A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 YearsNo drug interventionsprevention1completed
NCT05794191
A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIVNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01432262
13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in MexicoNo drug interventionsprevention3completed
NCT00000829
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected InfantsNo drug interventionsprevention1completed
NCT03574389
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young ChildrenNo drug interventionsprevention3completed
NCT00142389
Mother's Gift ProjectNo drug interventionsprevention1 / 2completed
NCT04214444
Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximabother3unknown_status
NCT02927444
Immunogenicity and Safety Study of NBP606 in Healthy ToddlersNo drug interventionsprevention3completed
NCT05145101
Pneumococcal Vaccination in Patients With Chronic Lymphocytic LeukaemiaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01444001
Study of an Investigational Pneumococcal Vaccine in Healthy Adult VolunteersNo drug interventionsprevention1completed
NCT02987972
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)prevention2completed
NCT02451969
Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and ElderlyNo drug interventionsprevention3completed
NCT04841369
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)prevention3completed
NCT04031846
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)prevention3completed
NCT02972281
Systematic Search for Primary Immunodeficiency in Adults With InfectionsNo drug interventionsdiagnosticNot Availableterminated
NCT02573181
Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)prevention2completed
NCT00427895
Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in AdultsNo drug interventionsprevention3completed
NCT04016714
Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)treatment3completed
NCT05982314
Extension Safety and Immunogenicity Study of GPNV-001prevention1 / 2recruiting
NCT03313050
A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of AgeNo drug interventionsprevention2completed
NCT00197808
Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccinesprevention4completed
NCT00452790
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in IndiaNo drug interventionsprevention3completed
NCT00195390
Study Investigating Administration of Prevenar for Post-Marketing SurveillanceNo drug interventionsNot AvailableNot Availablecompleted
NCT02037984
Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)prevention1 / 2completed
NCT00000933
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048No drug interventionsNot AvailableNot Availablecompleted
NCT02123433
Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV AdultsNo drug interventionsprevention3completed
NCT00127153
A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)No drug interventionstreatment3completed
NCT00625677
Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Lifeprevention4completed
NCT03642847
Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Ageprevention1completed
NCT03552445
Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate VaccineNo drug interventionsprevention4completed
NCT02637583
Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levelsprevention4completed
NCT00195611
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaNo drug interventionsNot AvailableNot Availablecompleted
NCT05477693
Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide VaccineNo drug interventionsprevention4completed
NCT00488371
Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®Not AvailableNot Availablecompleted
NCT00013871
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugspreventionNot Availablecompleted
NCT03692871
A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)prevention3completed
NCT01215188
A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)prevention2completed
NCT02079207
Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate VaccineNo drug interventionsprevention3completed
NCT00276107
Study Evaluating Prevenar Vaccine in Healthy InfantsNo drug interventionsprevention4completed
NCT02012309
Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine ResponsespreventionNot Availableunknown_status
NCT04664556
Invasive Pneumococcal Disease StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03950856
Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)prevention3completed
NCT01444352
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adultsprevention1completed
NCT00452452
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and ChildrenNo drug interventionsprevention3completed
NCT03565900
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)prevention3completed
NCT00488800
Safety and Local Tolerability of Prevenar in Indian ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT02615470
Enhancing a Sustainable Pharmacy-based Immunization Program in Two StatesNo drug interventionshealth_services_researchNot Availablecompleted
NCT00508742
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal ColonizationNo drug interventionsprevention3completed
NCT02547649
Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)prevention2completed
NCT03550313
Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infantsprevention2terminated
NCT04875819
Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIVprevention4recruiting
NCT03885934
Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024)prevention3completed
NCT00099658
Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected ChildrenNo drug interventionspreventionNot Availableunknown_status
NCT00963235
Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPSNo drug interventionsprevention3completed
NCT03480763
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)prevention3completed
NCT02787863
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathologytreatment4completed
NCT01444339
Study of Two Investigational Pneumococcal Vaccines in Healthy Adultsprevention1completed
NCT00273325
Immunogenicity of PCV-7 Vaccine in VLBW InfantsNo drug interventionsNot AvailableNot Availablecompleted
NCT03893448
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)prevention3completed
NCT03848065
Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028)prevention1completed
NCT04989465
A Clinical Trial of 23-valent Pneumococcal Polysaccharide VaccineNo drug interventionsprevention4completed
NCT03615482
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)prevention3completed
NCT00304382
Humoral Determinants of Immunity to Pneumococcal Infectionprevention4completed
NCT02583373
Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus PneumoniaeNo drug interventionstreatment1completed
NCT02531373
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)prevention1 / 2completed
NCT03620162
A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)prevention3completed
NCT05602480
Phase I Clinical Trial of a Candidate PCV13 in Healthy Peopleprevention1recruiting
NCT00962780
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal VaccineNo drug interventionsprevention3completed
NCT05667740
Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.treatment1completed
NCT03547167
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)prevention3completed
NCT04100772
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Aboveprevention1completed
NCT00546572
Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)No drug interventionsprevention3completed
NCT02892812
A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in AdultsNo drug interventionsprevention1completed
NCT00170612
Pneumococcal Vaccination of Fiji Infantsprevention2completed
NCT04945681
Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced PeopleNo drug interventionsprevention4unknown_status
NCT05229081
Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT02357823
Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV AdultsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00479323
Pneumococcal Reference Standardprevention1completed